NXHLillian: adjusted structure based on references and corrected details after review

2026-03-23T18:14:19Z

adjusted structure based on references and corrected details after review

Show changes

WikiDwarfBOT: Cleanup: Source modification. Information added.

2023-07-22T02:41:27Z

Cleanup: Source modification. Information added.

Show changes

WikiDwarfBOT: /* External links */Replace {{Source}} tag

2021-04-30T10:27:30Z

External links: Replace {{Source}} tag

← Older revision		Revision as of 15:57, 30 April 2021
Line 262:		Line 262:
	* {{cite web \|title=Coronavirus in India: Latest Map and Case Count \|url=https://www.covid19india.org \|website=www.covid19india.org \|publisher=A crowdsourced initiative. \|language=en}} (javascript required)		* {{cite web \|title=Coronavirus in India: Latest Map and Case Count \|url=https://www.covid19india.org \|website=www.covid19india.org \|publisher=A crowdsourced initiative. \|language=en}} (javascript required)
	* {{cite web \|url=https://graphics.reuters.com/world-coronavirus-tracker-and-maps/countries-and-territories/india/ \|publisher=Reuters.com \|title=Reuters Covid-19 Tracker India. Current charts of infections, deaths, vaccinations}}		* {{cite web \|url=https://graphics.reuters.com/world-coronavirus-tracker-and-maps/countries-and-territories/india/ \|publisher=Reuters.com \|title=Reuters Covid-19 Tracker India. Current charts of infections, deaths, vaccinations}}
	~~{{Source\|Wiki\|E}}~~
	[[Category:COVID-19 pandemic in India\| ]]		[[Category:COVID-19 pandemic in India\| ]]
	[[Category:COVID-19 pandemic in Asia\|India]]		[[Category:COVID-19 pandemic in Asia\|India]]
Line 269:		Line 269:
	[[Category:2021 in India\|coronavirus pandemic]]		[[Category:2021 in India\|coronavirus pandemic]]
	[[Category:Disease outbreaks in India]]		[[Category:Disease outbreaks in India]]

			{{en-Wikipedia}}

WikiDwarf at 12:22, 28 April 2021

2021-04-28T12:22:59Z

← Older revision		Revision as of 17:52, 28 April 2021
Line 245:		Line 245:
	==See also==		==See also==
	* [[COVID-19 vaccination in India]]		* [[COVID-19 vaccination in India]]
	* [[COVID-19 pandemic in South Asia]]
	* [[SAARC COVID-19 Emergency Fund]]
	* [[Vaccine Maitri]]		* [[Vaccine Maitri]]

WikiDwarf: Timeline

2021-04-28T12:13:35Z

Timeline

Show changes

WikiDwarf at 11:48, 28 April 2021

2021-04-28T11:48:50Z

Show changes

WikiDwarf: Vaccination

2021-04-28T11:46:08Z

Vaccination

← Older revision		Revision as of 17:16, 28 April 2021
Line 148:		Line 148:

	On 23 April 2021, [[Cadila Healthcare]] received an emergency authorisation to repurpose [[Peginterferon alfa-2b]], a medication used to treat [[hepatitis C]], as a treatment for moderate COVID-19 in adults.<ref>{{Cite web\|date=2021-04-23\|title=India's Cadila gets approval to repurpose Hepatitis C drug for Covid-19\|url=https://www.hindustantimes.com/india-news/indias-cadila-gets-approval-to-repurpose-hepatitis-c-drug-for-covid19-101619171912735.html\|access-date=2021-04-24\|website=Hindustan Times\|language=en}}</ref>		On 23 April 2021, [[Cadila Healthcare]] received an emergency authorisation to repurpose [[Peginterferon alfa-2b]], a medication used to treat [[hepatitis C]], as a treatment for moderate COVID-19 in adults.<ref>{{Cite web\|date=2021-04-23\|title=India's Cadila gets approval to repurpose Hepatitis C drug for Covid-19\|url=https://www.hindustantimes.com/india-news/indias-cadila-gets-approval-to-repurpose-hepatitis-c-drug-for-covid19-101619171912735.html\|access-date=2021-04-24\|website=Hindustan Times\|language=en}}</ref>

			===Vaccination ===
			{{main\|COVID-19 vaccination in India}}
			[[File:The Union Minister for Health & Family Welfare, Science & Technology and Earth Sciences, Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on January 02, 2021 (2).jpg\|thumb\|Union Minister for Health & Family Welfare, [[Harsh Vardhan (Delhi politician)\|Dr. Harsh Vardhan]] visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on 2 January 2021.]]

			In September 2020, federal science minister [[Harsh Vardhan (Delhi politician)\|Harsh Vardhan]] stated that the country planned to have a [[COVID-19 vaccine]] approved within the first quarter of 2021.<ref>{{Cite news\|title=Expect Covid-19 vaccine by early next year, will take first shot if any trust deficit: Vardhan\|url=https://m.timesofindia.com/india/covid-vaccine-likely-by-early-2021-for-old-high-risk-first-harsh-vardhan/articleshow/78091084.cms\|newspaper=The Times of India\|date=2020-09-13\|access-date=2020-09-13}}</ref> 30 million health workers directly dealing with COVID patients, especially doctors and other medical personnel, were to be prioritised as part of Phase 1.<ref>{{Cite news\|location=New Delhi\|last=Kaul\|first=Rhythma\|title=30 Million Frontline Workers To Get Covid-19 Vaccine In Phase 1\|url=https://m.hindustantimes.com/india-news/30-million-frontline-workers-to-get-covid-19-vaccine-in-phase-1/story-W76e1pJ7toA4aod3hH234O.html\|newspaper=Hindustan Times\|date=2020-10-21\|access-date=2020-10-21}}</ref>

			On 1 January 2021, the [[Drug Controller General of India]] granted an emergency use authorisation to the British [[Oxford–AstraZeneca COVID-19 vaccine\|Oxford–AstraZeneca vaccine]], which is being produced locally by the [[Serum Institute of India]] under the trade name "Covishield" for domestic use and export.<ref>{{Cite news\|others=PTI\|date=2020-12-28\|title=Already produced 40-50 million dosages of Covishield vaccine, says Serum Institute\|language=en-IN\|work=The Hindu\|url=https://www.thehindu.com/business/Industry/already-produced-40-50-million-dosages-of-covishield-vaccine-says-serum-institute/article33438655.ece\|access-date=2021-04-26\|issn=0971-751X}}</ref><ref>{{Cite news\|last=Schmall\|first=Emily\|last2=Yasir\|first2=Sameer\|date=2021-01-03\|title=India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other\|language=en-US\|work=The New York Times\|url=https://www.nytimes.com/2021/01/03/world/asia/india-covid-19-vaccine.html\|access-date=2021-04-22\|issn=0362-4331}}</ref><ref>{{Cite news\|date=2021-01-03\|title=Coronavirus: India approves vaccines from Bharat Biotech and Oxford/AstraZeneca\|language=en-GB\|work=BBC News\|url=https://www.bbc.com/news/world-asia-india-55520658\|access-date=2021-04-22}}</ref><ref name=":16" /><ref>{{Cite news\|date=2021-04-06\|title=Why is the EU unhappy with AstraZeneca?\|language=en-GB\|work=BBC News\|url=https://www.bbc.com/news/56483766\|access-date=2021-04-22}}</ref>

			On 2 January, the country also approved [[BBV152]] (Covaxin), a domestic vaccine developed by [[Bharat Biotech]] in association with the [[Indian Council of Medical Research]] and [[National Institute of Virology]].<ref>{{cite news\|date=2 January 2021\|title=Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use\|publisher=News18\|url=https://www.news18.com/news/india/expert-panel-clears-bharat-biotechs-covaxin-amid-uk-virus-strain-what-you-need-to-know-3240500.html\|access-date=2 January 2021}}</ref> This approval was met with some concern, as the vaccine had not then completed phase 3 trials.<ref>{{Cite news\|last=Prasad\|first=R\|date=2020-01-15\|title=Vaccine dilemma — to take or not to take Covaxin\|newspaper=The Hindu\|location=Chennai\|url=https://www.thehindu.com/sci-tech/health/vaccine-dilemma-to-take-or-not-to-take-covaxin/article33577223.ecel\|access-date=2020-01-16}}</ref>

			India officially launched its vaccination program on 16 January, Over {{Lakh\|1.6}} doses were administered on the first day.<ref>{{Cite web\|date=2021-01-16\|title=Covid-19 vaccination in India Day 1: Over 1.9 lakh people inoculated, says govt\|url=https://www.livemint.com/news/india/covid19-vaccination-in-india-day-1-over-1-6-lakh-people-inoculated-3-351-sessions-held-says-govt-11610804057599.html\|access-date=2021-04-23\|website=mint\|language=en}}</ref>

			Due to the second wave, in late-March 2021 the country placed a hold on all exports of the AstraZeneca vaccine in order to meet local demand.<ref name=":16" /> In April 2021, India approved the Russian [[Sputnik V COVID-19 vaccine\|Sputnik V]] vaccine.<ref name=":13" />

	==See also==		==See also==

WikiDwarf: From Wikipedia.org

2021-04-28T11:37:00Z

From Wikipedia.org

Show changes

← Older revision		Revision as of 15:57, 30 April 2021
Line 262:		Line 262:
	* {{cite web \|title=Coronavirus in India: Latest Map and Case Count \|url=https://www.covid19india.org \|website=www.covid19india.org \|publisher=A crowdsourced initiative. \|language=en}} (javascript required)		* {{cite web \|title=Coronavirus in India: Latest Map and Case Count \|url=https://www.covid19india.org \|website=www.covid19india.org \|publisher=A crowdsourced initiative. \|language=en}} (javascript required)
	* {{cite web \|url=https://graphics.reuters.com/world-coronavirus-tracker-and-maps/countries-and-territories/india/ \|publisher=Reuters.com \|title=Reuters Covid-19 Tracker India. Current charts of infections, deaths, vaccinations}}		* {{cite web \|url=https://graphics.reuters.com/world-coronavirus-tracker-and-maps/countries-and-territories/india/ \|publisher=Reuters.com \|title=Reuters Covid-19 Tracker India. Current charts of infections, deaths, vaccinations}}
	~~{{Source\|Wiki\|E}}~~
	[[Category:COVID-19 pandemic in India\| ]]		[[Category:COVID-19 pandemic in India\| ]]
	[[Category:COVID-19 pandemic in Asia\|India]]		[[Category:COVID-19 pandemic in Asia\|India]]
Line 269:		Line 269:
	[[Category:2021 in India\|coronavirus pandemic]]		[[Category:2021 in India\|coronavirus pandemic]]
	[[Category:Disease outbreaks in India]]		[[Category:Disease outbreaks in India]]

			{{en-Wikipedia}}

← Older revision		Revision as of 17:16, 28 April 2021
Line 148:		Line 148:

	On 23 April 2021, [[Cadila Healthcare]] received an emergency authorisation to repurpose [[Peginterferon alfa-2b]], a medication used to treat [[hepatitis C]], as a treatment for moderate COVID-19 in adults.<ref>{{Cite web\|date=2021-04-23\|title=India's Cadila gets approval to repurpose Hepatitis C drug for Covid-19\|url=https://www.hindustantimes.com/india-news/indias-cadila-gets-approval-to-repurpose-hepatitis-c-drug-for-covid19-101619171912735.html\|access-date=2021-04-24\|website=Hindustan Times\|language=en}}</ref>		On 23 April 2021, [[Cadila Healthcare]] received an emergency authorisation to repurpose [[Peginterferon alfa-2b]], a medication used to treat [[hepatitis C]], as a treatment for moderate COVID-19 in adults.<ref>{{Cite web\|date=2021-04-23\|title=India's Cadila gets approval to repurpose Hepatitis C drug for Covid-19\|url=https://www.hindustantimes.com/india-news/indias-cadila-gets-approval-to-repurpose-hepatitis-c-drug-for-covid19-101619171912735.html\|access-date=2021-04-24\|website=Hindustan Times\|language=en}}</ref>

			===Vaccination ===
			{{main\|COVID-19 vaccination in India}}
			[[File:The Union Minister for Health & Family Welfare, Science & Technology and Earth Sciences, Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on January 02, 2021 (2).jpg\|thumb\|Union Minister for Health & Family Welfare, [[Harsh Vardhan (Delhi politician)\|Dr. Harsh Vardhan]] visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on 2 January 2021.]]

			In September 2020, federal science minister [[Harsh Vardhan (Delhi politician)\|Harsh Vardhan]] stated that the country planned to have a [[COVID-19 vaccine]] approved within the first quarter of 2021.<ref>{{Cite news\|title=Expect Covid-19 vaccine by early next year, will take first shot if any trust deficit: Vardhan\|url=https://m.timesofindia.com/india/covid-vaccine-likely-by-early-2021-for-old-high-risk-first-harsh-vardhan/articleshow/78091084.cms\|newspaper=The Times of India\|date=2020-09-13\|access-date=2020-09-13}}</ref> 30 million health workers directly dealing with COVID patients, especially doctors and other medical personnel, were to be prioritised as part of Phase 1.<ref>{{Cite news\|location=New Delhi\|last=Kaul\|first=Rhythma\|title=30 Million Frontline Workers To Get Covid-19 Vaccine In Phase 1\|url=https://m.hindustantimes.com/india-news/30-million-frontline-workers-to-get-covid-19-vaccine-in-phase-1/story-W76e1pJ7toA4aod3hH234O.html\|newspaper=Hindustan Times\|date=2020-10-21\|access-date=2020-10-21}}</ref>

			On 1 January 2021, the [[Drug Controller General of India]] granted an emergency use authorisation to the British [[Oxford–AstraZeneca COVID-19 vaccine\|Oxford–AstraZeneca vaccine]], which is being produced locally by the [[Serum Institute of India]] under the trade name "Covishield" for domestic use and export.<ref>{{Cite news\|others=PTI\|date=2020-12-28\|title=Already produced 40-50 million dosages of Covishield vaccine, says Serum Institute\|language=en-IN\|work=The Hindu\|url=https://www.thehindu.com/business/Industry/already-produced-40-50-million-dosages-of-covishield-vaccine-says-serum-institute/article33438655.ece\|access-date=2021-04-26\|issn=0971-751X}}</ref><ref>{{Cite news\|last=Schmall\|first=Emily\|last2=Yasir\|first2=Sameer\|date=2021-01-03\|title=India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other\|language=en-US\|work=The New York Times\|url=https://www.nytimes.com/2021/01/03/world/asia/india-covid-19-vaccine.html\|access-date=2021-04-22\|issn=0362-4331}}</ref><ref>{{Cite news\|date=2021-01-03\|title=Coronavirus: India approves vaccines from Bharat Biotech and Oxford/AstraZeneca\|language=en-GB\|work=BBC News\|url=https://www.bbc.com/news/world-asia-india-55520658\|access-date=2021-04-22}}</ref><ref name=":16" /><ref>{{Cite news\|date=2021-04-06\|title=Why is the EU unhappy with AstraZeneca?\|language=en-GB\|work=BBC News\|url=https://www.bbc.com/news/56483766\|access-date=2021-04-22}}</ref>

			On 2 January, the country also approved [[BBV152]] (Covaxin), a domestic vaccine developed by [[Bharat Biotech]] in association with the [[Indian Council of Medical Research]] and [[National Institute of Virology]].<ref>{{cite news\|date=2 January 2021\|title=Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use\|publisher=News18\|url=https://www.news18.com/news/india/expert-panel-clears-bharat-biotechs-covaxin-amid-uk-virus-strain-what-you-need-to-know-3240500.html\|access-date=2 January 2021}}</ref> This approval was met with some concern, as the vaccine had not then completed phase 3 trials.<ref>{{Cite news\|last=Prasad\|first=R\|date=2020-01-15\|title=Vaccine dilemma — to take or not to take Covaxin\|newspaper=The Hindu\|location=Chennai\|url=https://www.thehindu.com/sci-tech/health/vaccine-dilemma-to-take-or-not-to-take-covaxin/article33577223.ecel\|access-date=2020-01-16}}</ref>

			India officially launched its vaccination program on 16 January, Over {{Lakh\|1.6}} doses were administered on the first day.<ref>{{Cite web\|date=2021-01-16\|title=Covid-19 vaccination in India Day 1: Over 1.9 lakh people inoculated, says govt\|url=https://www.livemint.com/news/india/covid19-vaccination-in-india-day-1-over-1-6-lakh-people-inoculated-3-351-sessions-held-says-govt-11610804057599.html\|access-date=2021-04-23\|website=mint\|language=en}}</ref>

			Due to the second wave, in late-March 2021 the country placed a hold on all exports of the AstraZeneca vaccine in order to meet local demand.<ref name=":16" /> In April 2021, India approved the Russian [[Sputnik V COVID-19 vaccine\|Sputnik V]] vaccine.<ref name=":13" />

	==See also==		==See also==

COVID-19 pandemic in India - Revision history

NXHLillian: adjusted structure based on references and corrected details after review

WikiDwarfBOT: Cleanup: Source modification. Information added.

WikiDwarfBOT: /* External links */Replace {{Source}} tag

WikiDwarf at 12:22, 28 April 2021

WikiDwarf: Timeline

WikiDwarf at 11:48, 28 April 2021

WikiDwarf: Vaccination

WikiDwarf: From Wikipedia.org